Cowen Starts Uniqure At Outperform, Sees Hemophilia As 'Most Significant' Near-Term Catalyst
July 15, 2015 at 10:36 AM EDT
In a report published Wednesday, Cowen & Co analyst Ritu Baral initiated coverage of Uniqure NV (NASDAQ: QURE) with an Outperform ...
